IV and Oral Iron Drugs Market Insights, Global Outlook and Forecast 2022-2028
IV and Oral Iron Drugs Market Insights, Global Outlook and Forecast 2022-2028
The IV and Oral Iron Drugs study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The latest research study released by Market IntelliX evaluates market size and forecasts of IV and Oral Iron Drugs in Global, including the following market information:
Global IV and Oral Iron Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global IV and Oral Iron Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Iron Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of IV and Oral Iron Drugs include Daiichi Sankyo Company, Vifor Pharma, Akebia Therapeutics, Allergan, AMAG Pharmaceuticals, AOP Orphan Pharmaceuticals, Pharmacosmos, Sanofi and Shield Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the IV and Oral Iron Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global IV and Oral Iron Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global IV and Oral Iron Drugs Market Segment Percentages, by Type, 2021 (%)
Oral Iron Drug
IVIron Drugs
Global IV and Oral Iron Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global IV and Oral Iron Drugs Market Segment Percentages, by Application, 2021 (%)
Nephrology
OBGYN
Surgeries
Gastroenterology
Oncology
Heart failure (HF)
Global IV and Oral Iron Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global IV and Oral Iron Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies IV and Oral Iron Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies IV and Oral Iron Drugs revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Daiichi Sankyo Company
Vifor Pharma
Akebia Therapeutics
Allergan
AMAG Pharmaceuticals
AOP Orphan Pharmaceuticals
Pharmacosmos
Sanofi
Shield Therapeutics
AZAD Pharma
Cirondrugs
MEDICE
Pfizer
Salveo Lifecare
Sunny Pharmaceutical
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 IV and Oral Iron Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global IV and Oral Iron Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global IV and Oral Iron Drugs Overall Market Size
2.1 Global IV and Oral Iron Drugs Market Size: 2021 VS 2028
2.2 Global IV and Oral Iron Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top IV and Oral Iron Drugs Players in Global Market
3.2 Top Global IV and Oral Iron Drugs Companies Ranked by Revenue
3.3 Global IV and Oral Iron Drugs Revenue by Companies
3.4 Top 3 and Top 5 IV and Oral Iron Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies IV and Oral Iron Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 IV and Oral Iron Drugs Players in Global Market
3.6.1 List of Global Tier 1 IV and Oral Iron Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 IV and Oral Iron Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global IV and Oral Iron Drugs Market Size Markets, 2021 & 2028
4.1.2 Oral Iron Drug
4.1.3 IVIron Drugs
4.2 By Type - Global IV and Oral Iron Drugs Revenue & Forecasts
4.2.1 By Type - Global IV and Oral Iron Drugs Revenue, 2017-2022
4.2.2 By Type - Global IV and Oral Iron Drugs Revenue, 2023-2028
4.2.3 By Type - Global IV and Oral Iron Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global IV and Oral Iron Drugs Market Size, 2021 & 2028
5.1.2 Nephrology
5.1.3 OBGYN
5.1.4 Surgeries
5.1.5 Gastroenterology
5.1.6 Oncology
5.1.7 Heart failure (HF)
5.2 By Application - Global IV and Oral Iron Drugs Revenue & Forecasts
5.2.1 By Application - Global IV and Oral Iron Drugs Revenue, 2017-2022
5.2.2 By Application - Global IV and Oral Iron Drugs Revenue, 2023-2028
5.2.3 By Application - Global IV and Oral Iron Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global IV and Oral Iron Drugs Market Size, 2021 & 2028
6.2 By Region - Global IV and Oral Iron Drugs Revenue & Forecasts
6.2.1 By Region - Global IV and Oral Iron Drugs Revenue, 2017-2022
6.2.2 By Region - Global IV and Oral Iron Drugs Revenue, 2023-2028
6.2.3 By Region - Global IV and Oral Iron Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America IV and Oral Iron Drugs Revenue, 2017-2028
6.3.2 US IV and Oral Iron Drugs Market Size, 2017-2028
6.3.3 Canada IV and Oral Iron Drugs Market Size, 2017-2028
6.3.4 Mexico IV and Oral Iron Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe IV and Oral Iron Drugs Revenue, 2017-2028
6.4.2 Germany IV and Oral Iron Drugs Market Size, 2017-2028
6.4.3 France IV and Oral Iron Drugs Market Size, 2017-2028
6.4.4 U.K. IV and Oral Iron Drugs Market Size, 2017-2028
6.4.5 Italy IV and Oral Iron Drugs Market Size, 2017-2028
6.4.6 Russia IV and Oral Iron Drugs Market Size, 2017-2028
6.4.7 Nordic Countries IV and Oral Iron Drugs Market Size, 2017-2028
6.4.8 Benelux IV and Oral Iron Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia IV and Oral Iron Drugs Revenue, 2017-2028
6.5.2 China IV and Oral Iron Drugs Market Size, 2017-2028
6.5.3 Japan IV and Oral Iron Drugs Market Size, 2017-2028
6.5.4 South Korea IV and Oral Iron Drugs Market Size, 2017-2028
6.5.5 Southeast Asia IV and Oral Iron Drugs Market Size, 2017-2028
6.5.6 India IV and Oral Iron Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America IV and Oral Iron Drugs Revenue, 2017-2028
6.6.2 Brazil IV and Oral Iron Drugs Market Size, 2017-2028
6.6.3 Argentina IV and Oral Iron Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa IV and Oral Iron Drugs Revenue, 2017-2028
6.7.2 Turkey IV and Oral Iron Drugs Market Size, 2017-2028
6.7.3 Israel IV and Oral Iron Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia IV and Oral Iron Drugs Market Size, 2017-2028
6.7.5 UAE IV and Oral Iron Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Daiichi Sankyo Company
7.1.1 Daiichi Sankyo Company Corporate Summary
7.1.2 Daiichi Sankyo Company Business Overview
7.1.3 Daiichi Sankyo Company IV and Oral Iron Drugs Major Product Offerings
7.1.4 Daiichi Sankyo Company IV and Oral Iron Drugs Revenue in Global Market (2017-2022)
7.1.5 Daiichi Sankyo Company Key News
7.2 Vifor Pharma
7.2.1 Vifor Pharma Corporate Summary
7.2.2 Vifor Pharma Business Overview
7.2.3 Vifor Pharma IV and Oral Iron Drugs Major Product Offerings
7.2.4 Vifor Pharma IV and Oral Iron Drugs Revenue in Global Market (2017-2022)
7.2.5 Vifor Pharma Key News
7.3 Akebia Therapeutics
7.3.1 Akebia Therapeutics Corporate Summary
7.3.2 Akebia Therapeutics Business Overview
7.3.3 Akebia Therapeutics IV and Oral Iron Drugs Major Product Offerings
7.3.4 Akebia Therapeutics IV and Oral Iron Drugs Revenue in Global Market (2017-2022)
7.3.5 Akebia Therapeutics Key News
7.4 Allergan
7.4.1 Allergan Corporate Summary
7.4.2 Allergan Business Overview
7.4.3 Allergan IV and Oral Iron Drugs Major Product Offerings
7.4.4 Allergan IV and Oral Iron Drugs Revenue in Global Market (2017-2022)
7.4.5 Allergan Key News
7.5 AMAG Pharmaceuticals
7.5.1 AMAG Pharmaceuticals Corporate Summary
7.5.2 AMAG Pharmaceuticals Business Overview
7.5.3 AMAG Pharmaceuticals IV and Oral Iron Drugs Major Product Offerings
7.5.4 AMAG Pharmaceuticals IV and Oral Iron Drugs Revenue in Global Market (2017-2022)
7.5.5 AMAG Pharmaceuticals Key News
7.6 AOP Orphan Pharmaceuticals
7.6.1 AOP Orphan Pharmaceuticals Corporate Summary
7.6.2 AOP Orphan Pharmaceuticals Business Overview
7.6.3 AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Major Product Offerings
7.6.4 AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Revenue in Global Market (2017-2022)
7.6.5 AOP Orphan Pharmaceuticals Key News
7.7 Pharmacosmos
7.7.1 Pharmacosmos Corporate Summary
7.7.2 Pharmacosmos Business Overview
7.7.3 Pharmacosmos IV and Oral Iron Drugs Major Product Offerings
7.7.4 Pharmacosmos IV and Oral Iron Drugs Revenue in Global Market (2017-2022)
7.7.5 Pharmacosmos Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi IV and Oral Iron Drugs Major Product Offerings
7.8.4 Sanofi IV and Oral Iron Drugs Revenue in Global Market (2017-2022)
7.8.5 Sanofi Key News
7.9 Shield Therapeutics
7.9.1 Shield Therapeutics Corporate Summary
7.9.2 Shield Therapeutics Business Overview
7.9.3 Shield Therapeutics IV and Oral Iron Drugs Major Product Offerings
7.9.4 Shield Therapeutics IV and Oral Iron Drugs Revenue in Global Market (2017-2022)
7.9.5 Shield Therapeutics Key News
7.10 AZAD Pharma
7.10.1 AZAD Pharma Corporate Summary
7.10.2 AZAD Pharma Business Overview
7.10.3 AZAD Pharma IV and Oral Iron Drugs Major Product Offerings
7.10.4 AZAD Pharma IV and Oral Iron Drugs Revenue in Global Market (2017-2022)
7.10.5 AZAD Pharma Key News
7.11 Cirondrugs
7.11.1 Cirondrugs Corporate Summary
7.11.2 Cirondrugs Business Overview
7.11.3 Cirondrugs IV and Oral Iron Drugs Major Product Offerings
7.11.4 Cirondrugs IV and Oral Iron Drugs Revenue in Global Market (2017-2022)
7.11.5 Cirondrugs Key News
7.12 MEDICE
7.12.1 MEDICE Corporate Summary
7.12.2 MEDICE Business Overview
7.12.3 MEDICE IV and Oral Iron Drugs Major Product Offerings
7.12.4 MEDICE IV and Oral Iron Drugs Revenue in Global Market (2017-2022)
7.12.5 MEDICE Key News
7.13 Pfizer
7.13.1 Pfizer Corporate Summary
7.13.2 Pfizer Business Overview
7.13.3 Pfizer IV and Oral Iron Drugs Major Product Offerings
7.13.4 Pfizer IV and Oral Iron Drugs Revenue in Global Market (2017-2022)
7.13.5 Pfizer Key News
7.14 Salveo Lifecare
7.14.1 Salveo Lifecare Corporate Summary
7.14.2 Salveo Lifecare Business Overview
7.14.3 Salveo Lifecare IV and Oral Iron Drugs Major Product Offerings
7.14.4 Salveo Lifecare IV and Oral Iron Drugs Revenue in Global Market (2017-2022)
7.14.5 Salveo Lifecare Key News
7.15 Sunny Pharmaceutical
7.15.1 Sunny Pharmaceutical Corporate Summary
7.15.2 Sunny Pharmaceutical Business Overview
7.15.3 Sunny Pharmaceutical IV and Oral Iron Drugs Major Product Offerings
7.15.4 Sunny Pharmaceutical IV and Oral Iron Drugs Revenue in Global Market (2017-2022)
7.15.5 Sunny Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
IV and Oral Iron Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|